Viewing StudyNCT02504892



Ignite Creation Date: 2024-05-06 @ 7:16 AM
Last Modification Date: 2024-10-26 @ 11:46 AM
Study NCT ID: NCT02504892
Status: TERMINATED
Last Update Posted: 2019-03-22
First Post: 2015-07-21

Brief Title: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome BHD-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Renal Cancer
Birt-Hogg-Dube Syndrome
Keywords:
Name View
mTOR Therapy Naive View
Overall Response Rate View
Hereditary Cancer Syndrome View